Trade Precision BioSciences, Inc. - DTIL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1326 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.001 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.7187 |
| Open | 9.6287 |
| 1-Year Change | 1008.15% |
| Day's Range | 9.3787 - 9.7287 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | 9.3787 | -0.2400 | -2.50% | 9.6187 | 9.7287 | 9.3287 |
| Apr 25, 2024 | 9.7187 | -0.2800 | -2.80% | 9.9987 | 9.9987 | 9.6187 |
| Apr 24, 2024 | 9.8187 | 0.1400 | 1.45% | 9.6787 | 10.0987 | 9.6787 |
| Apr 23, 2024 | 10.1887 | 0.5400 | 5.60% | 9.6487 | 10.3387 | 9.5987 |
| Apr 22, 2024 | 9.6487 | -0.1000 | -1.03% | 9.7487 | 9.8387 | 9.0987 |
| Apr 19, 2024 | 9.5987 | -0.9000 | -8.57% | 10.4987 | 10.5587 | 9.4387 |
| Apr 18, 2024 | 10.7187 | -0.6800 | -5.97% | 11.3987 | 11.5687 | 10.5587 |
| Apr 17, 2024 | 11.4587 | 0.0800 | 0.70% | 11.3787 | 11.7987 | 11.1487 |
| Apr 16, 2024 | 12.8587 | 0.0300 | 0.23% | 12.8287 | 12.9987 | 12.6487 |
| Apr 15, 2024 | 12.9987 | -1.0100 | -7.21% | 14.0087 | 14.1587 | 12.5487 |
| Apr 12, 2024 | 14.1287 | 0.1300 | 0.93% | 13.9987 | 14.4687 | 13.8987 |
| Apr 11, 2024 | 14.4387 | 0.4200 | 3.00% | 14.0187 | 14.4587 | 13.4287 |
| Apr 10, 2024 | 13.9787 | 0.4500 | 3.33% | 13.5287 | 14.0487 | 13.0487 |
| Apr 9, 2024 | 13.8287 | 0.5000 | 3.75% | 13.3287 | 13.8287 | 13.0187 |
| Apr 8, 2024 | 13.4787 | -0.7700 | -5.40% | 14.2487 | 14.2787 | 13.0087 |
| Apr 5, 2024 | 14.2587 | 0.2500 | 1.78% | 14.0087 | 14.7687 | 13.9487 |
| Apr 4, 2024 | 14.3187 | -0.6800 | -4.53% | 14.9987 | 15.1987 | 13.8687 |
| Apr 3, 2024 | 15.3787 | 1.1700 | 8.23% | 14.2087 | 15.9187 | 14.1987 |
| Apr 2, 2024 | 14.1887 | -1.1800 | -7.68% | 15.3687 | 15.3687 | 13.6587 |
| Apr 1, 2024 | 15.3987 | 1.4800 | 10.63% | 13.9187 | 15.4787 | 13.6787 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Precision BioSciences, Inc. Company profile
About Precision BioSciences Inc
Precision BioSciences, Inc is a clinical stage biotechnology company. The Company’s ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. The Company’s pipeline includes Ex vivo Allogeneic CAR T Immunotherapy and In vivo Gene Correction. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. The Company’s subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Precision BioSciences Inc revenues increased from $24.3M to $115.5M. Net loss decreased 72% to $30.6M. Revenues reflect Therapeutics segment increase from $21.9M to $111.7M, Food segment increase of 57% to $3.8M. Lower net loss reflects Therapeutics segment income totaling $32M vs. loss of $50M, Food segment loss decrease of 26% to $3.8M.
| Industry: | Biotechnology & Medical Research (NEC) |
302 E Pettigrew St Ste A100
DURHAM
NORTH CAROLINA 27701-2393
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com